Autolus Therapeutics (AUTL) Institutional Ownership $1.45 +0.01 (+0.69%) Closing price 04:00 PM EasternExtended Trading$1.46 +0.01 (+0.34%) As of 06:33 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Autolus Therapeutics (NASDAQ:AUTL)CurrentInstitutional OwnershipPercentage72.83%Number ofInstitutional Buyers(last 12 months)60TotalInstitutional Inflows(last 12 months)$94.48MNumber ofInstitutional Sellers(last 12 months)25TotalInstitutional Outflows(last 12 months)$33.37M Get AUTL Insider Trade Alerts Want to know when executives and insiders are buying or selling Autolus Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data AUTL Institutional Buying and Selling by Quarter Autolus Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/19/2025 Marex Group plc12,500$28K0.0%N/A0.005% 8/15/2025 Bank of America Corp DE975,135$2.22M0.0%+2,891.7%0.366% 8/14/2025 Armistice Capital LLC12,000,000$27.36M0.5%+9.1%4.509% 8/14/2025 TFG Asset Management GP Ltd9,500,000$21.66M3.5%+10.5%3.570% 8/14/2025 The Manufacturers Life Insurance Company 38,419$88K0.0%+41.6%0.014% 8/14/2025 OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC 565,000$1.29M0.1%N/A0.212% 8/13/2025 Diametric Capital LP279,688$638K0.3%N/A0.105% 8/13/2025 Tema Etfs LLC120,388$274K0.1%+9.0%0.045% 8/13/2025 Virtus Investment Advisers LLC43,736$100K0.0%-28.3%0.016% 8/13/2025 Quadrature Capital Ltd96,216$220K0.0%N/A0.036% Get the Latest News and Ratings for AUTL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Autolus Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/12/2025 XTX Topco Ltd168,254$384K0.0%N/A0.063% 8/12/2025 MAI Capital Management21,234$48K0.0%-37.3%0.008% 8/12/2025 JPMorgan Chase & Co.914,743$2.09M0.0%-35.1%0.344% 8/11/2025 Knott David M Jr270,000$616K0.3%-35.7%0.101% 8/8/2025 Cetera Investment Advisers617,172$1.41M0.0%+17.6%0.232% 8/8/2025 Geode Capital Management LLC164,314$375K0.0%+90.5%0.062% 7/31/2025 R Squared Ltd21,746$50K0.0%N/A0.008% 7/30/2025 Privium Fund Management B.V.294,142$674K0.1%+16.9%0.111% 7/29/2025 Aubrey Capital Management Ltd452,200$1.05M0.4%+276.8%0.170% 7/25/2025 Delaney Dennis R24,000$55K0.0%N/A0.009% 7/25/2025 Vanguard Personalized Indexing Management LLC30,432$69K0.0%+63.5%0.011% 7/17/2025 Forefront Wealth Management Inc.26,870$61K0.0%N/A0.010% 7/15/2025 Wealth Effects LLC13,500$31K0.0%-62.8%0.005% 7/14/2025 Avanza Fonder AB53,522$122K0.0%+151.6%0.020% 7/14/2025 Atle Fund Management AB1,105,461$2.52M1.1%+130.5%0.415% 7/11/2025 Perpetual Ltd829,090$1.89M0.0%-32.2%0.312% 6/27/2025 Goldman Sachs Group Inc.50,411$78K0.0%-60.1%0.019% 5/19/2025 Jane Street Group LLC102,493$159K0.0%+809.4%0.039% 5/16/2025 Goldman Sachs Group Inc.50,411$78K0.0%-60.1%0.019% 5/15/2025 Armistice Capital LLC11,000,000$17.05M0.3%+19.6%4.133% 5/15/2025 MAI Capital Management33,866$52K0.0%-89.7%0.013% 5/15/2025 Vident Advisory LLC155,504$241K0.0%N/A0.058% 5/15/2025 Tema Etfs LLC110,428$171K0.1%N/A0.041% 5/14/2025 Affinity Asset Advisors LLC3,045,000$4.72M0.5%-32.3%1.144% 5/14/2025 Wellington Management Group LLP27,091,700$41.99M0.0%+6.9%10.179% 5/12/2025 Knott David M Jr420,000$651K0.3%N/A0.158% 5/12/2025 Invesco Ltd.32,738$51K0.0%+53.3%0.012% 5/9/2025 BIT Capital GmbH199,359$309K0.0%-68.7%0.075% 5/9/2025 Privium Fund Management B.V.251,674$390K0.1%+8.6%0.095% 5/6/2025 Cetera Investment Advisers524,872$814K0.0%+47.3%0.197% 4/30/2025 Alps Advisors Inc.199,709$310K0.0%-7.2%0.075% 4/28/2025 Vontobel Holding Ltd.138,783$215K0.0%-5.9%0.052% 4/24/2025 Perpetual Ltd1,223,743$1.90M0.0%-4.4%0.460% 4/17/2025 Exchange Traded Concepts LLC69,993$108K0.0%+67.2%0.026% 4/16/2025 Aubrey Capital Management Ltd119,998$197K0.1%+41.5%0.045% 4/15/2025 Avanza Fonder AB21,276$33K0.0%-33.0%0.008% 4/10/2025 Hennion & Walsh Asset Management Inc.386,001$598K0.0%+48.5%0.145% 3/24/2025 Wellington Management Group LLP25,345,680$59.56M0.0%+4.6%9.525% 2/21/2025 TFG Asset Management GP Ltd8,250,000$19.39M4.2%+3.1%3.100% 2/17/2025 Two Sigma Advisers LP333,400$783K0.0%+4.8%0.125% 2/17/2025 Two Sigma Investments LP906,767$2.13M0.0%+23.8%0.341% 2/17/2025 TFG Asset Management GP Ltd8,250,000$19.39M4.8%+3.1%3.100% 2/17/2025 Point72 Asset Management L.P.247,089$581K0.0%N/A0.093% 2/17/2025 OMERS ADMINISTRATION Corp36,300$85K0.0%N/A0.014% 2/17/2025 Millennium Management LLC1,653,241$3.89M0.0%+91.6%0.621% 2/17/2025 DAFNA Capital Management LLC586,667$1.38M0.4%+20.5%0.220% 2/17/2025 Deep Track Capital LP14,218,903$33.41M1.2%-6.9%5.344% 2/17/2025 Cetera Investment Advisers356,222$837K0.0%+169.9%0.134% 2/17/2025 Bank of America Corp DE46,598$110K0.0%-82.6%0.018% 2/17/2025 Bayesian Capital Management LP65,000$153K0.0%+177.8%0.024% 2/17/2025 BNP Paribas Financial Markets32,462$76K0.0%-51.6%0.012% 2/17/2025 AXA S.A.1,824,685$4.29M0.0%N/A0.686% 2/14/2025 Jane Street Group LLC11,271$26K0.0%N/A0.004% 2/14/2025 The Manufacturers Life Insurance Company28,333$67K0.0%-82.8%0.011% 2/14/2025 Virtus ETF Advisers LLC26,429$62K0.0%+29.9%0.010% 2/14/2025 Price T Rowe Associates Inc. MD2,939,241$6.91M0.0%-23.5%1.105% 2/14/2025 Eversept Partners LP98,895$232K0.0%-75.7%0.037% 2/14/2025 Avoro Capital Advisors LLC9,910,642$23.29M0.3%-19.7%3.725% 2/13/2025 Jump Financial LLC72,396$170K0.0%N/A0.027% 2/13/2025 Walleye Capital LLC75,940$178K0.0%-92.9%0.029% 2/13/2025 Barclays PLC11,859$28K0.0%+1,094.3%0.004% 2/13/2025 Renaissance Technologies LLC618,942$1.46M0.0%+146.7%0.233% 2/13/2025 Legal & General Group Plc297,736$697K0.0%+392.0%0.112% 2/13/2025 Wells Fargo & Company MN266,315$626K0.0%-31.0%0.100% 2/12/2025 HighPoint Advisor Group LLC78,620$185K0.0%N/A0.030% 2/12/2025 Wellington Management Group LLP25,345,680$59.56M0.0%+4.6%9.525% 2/12/2025 BIT Capital GmbH636,979$1.50M0.1%+147.0%0.239% 2/12/2025 JPMorgan Chase & Co.1,071,533$2.52M0.0%-16.6%0.403% 2/12/2025 Mitsubishi UFJ Asset Management Co. Ltd.82,411$194K0.0%+21.2%0.031% 2/11/2025 EntryPoint Capital LLC191,429$450K0.2%N/A0.072% 2/11/2025 Privium Fund Management B.V.231,674$544K0.1%+24.8%0.087% 2/7/2025 Daiwa Securities Group Inc.23,743$56K0.0%+55.5%0.009% 2/7/2025 Candriam S.C.A.3,191,401$7.50M0.0%N/A1.199% 2/6/2025 Syncona Portfolio Ltd16,640,720$39.11M73.8%-10.3%6.254% 2/4/2025 Bank of New York Mellon Corp1,673,994$3.93M0.0%-8.6%0.629% 2/4/2025 HealthInvest Partners AB479,644$1.06M0.5%+8.4%0.180% 2/3/2025 Handelsbanken Fonder AB73,300$172K0.0%+30.9%0.028% 1/30/2025 Vontobel Holding Ltd.147,419$346K0.0%-26.6%0.055% 1/29/2025 Aubrey Capital Management Ltd84,822$199K0.1%N/A0.032% 1/23/2025 Dumont & Blake Investment Advisors LLC15,000$35K0.0%N/A0.006% 1/22/2025 Wealth Effects LLC42,800$101K0.0%-16.1%0.016% 1/17/2025 Perpetual Ltd1,279,620$3.01M0.0%-20.0%0.481% 1/15/2025 Arkadios Wealth Advisors20,000$47K0.0%N/A0.008% 1/15/2025 Avanza Fonder AB31,770$75K0.0%N/A0.012% 1/15/2025 Hennion & Walsh Asset Management Inc.259,980$611K0.0%N/A0.098% 12/26/2024 JPMorgan Chase & Co.1,284,708$4.66M0.0%+145.3%0.483% 11/15/2024 Wellington Management Group LLP24,220,226$87.92M0.0%+35.4%9.102% 11/15/2024 State Street Corp606,544$2.20M0.0%+1.7%0.228% 11/15/2024 HighVista Strategies LLC533,024$1.94M0.7%+2.7%0.200% 11/15/2024 Erste Asset Management GmbH195,000$708K0.0%N/A0.073% (Data available from 1/1/2016 forward) AUTL Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of AUTL shares? During the previous two years, 99 institutional investors and hedge funds held shares of Autolus Therapeutics. The most heavily invested institutionals were FMR LLC ($64.52M), Wellington Management Group LLP ($41.99M), Syncona Portfolio Ltd ($39.11M), Deep Track Capital LP ($33.41M), Armistice Capital LLC ($27.36M), Avoro Capital Advisors LLC ($23.29M), and TFG Asset Management GP Ltd ($21.66M).Learn more on Autolus Therapeutics' institutional investors. What percentage of Autolus Therapeutics' stock is owned by institutional investors? 72.83% of Autolus Therapeutics' stock is owned by institutional investors. Learn more on AUTL's institutional investor holdings. Which institutional investors have been buying Autolus Therapeutics' stock? Of the 81 institutional investors that purchased Autolus Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Avoro Capital Advisors LLC ($12.35M), Wellington Management Group LLP ($10.33M), FMR LLC ($5.48M), Armistice Capital LLC ($4.38M), Candriam S.C.A. ($3.19M), Affinity Asset Advisors LLC ($3.15M), and Price T Rowe Associates Inc. MD ($2.49M). How much institutional buying is happening at Autolus Therapeutics? Institutional investors have bought a total of 34,667,803 shares in the last 24 months. This purchase volume represents approximately $94.48M in transactions. Which of Autolus Therapeutics' major shareholders have been selling company stock? Of the 25 institutional investors that sold Autolus Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Avoro Capital Advisors LLC ($2.44M), Syncona Portfolio Ltd ($1.91M), Perpetual Ltd ($1.57M), Affinity Asset Advisors LLC ($1.46M), Walleye Capital LLC ($1.11M), Deep Track Capital LP ($1.05M), and Price T Rowe Associates Inc. MD ($902.26K). How much institutional selling is happening at Autolus Therapeutics? Institutional investors have sold a total of 14,115,888 shares in the last 24 months. This volume of shares sold represents approximately $33.37M in transactions. Related Companies Dyne Therapeutics Institutional Ownership Apogee Therapeutics Institutional Ownership Twist Bioscience Institutional Ownership Beam Therapeutics Institutional Ownership Cidara Therapeutics Institutional Ownership Immunocore Institutional Ownership Biohaven Institutional Ownership WAVE Life Sciences Institutional Ownership Aurinia Pharmaceuticals Institutional Ownership Travere Therapeutics Institutional Ownership This page (NASDAQ:AUTL) was last updated on 9/4/2025 by MarketBeat.com Staff From Our PartnersCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredDid you spot this in the Oval Office last week?When Tim Cook stood in the Oval Office last week, all eyes were on the "unique 24K gold gift" he presented to ...InvestorPlace | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…A new set of 7 AI stocks are DOMINATING the market. Here’s why one financial guru says they could be the mo...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Autolus Therapeutics PLC Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Autolus Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
